DANA SCOTT: Open Payments
NPI 1154945178 · ARLINGTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$345 in 11 payments from 7 companies in 2025. Trend: 2023 $375 · 2024 $251 · 2025 $345
Food & beverage: $345
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $157 |
| ABBVIE INC. | 1 | $86 |
| Regeneron Pharmaceuticals, Inc. | 1 | $25 |
| Karyopharm Therapeutics Inc. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| GENZYME CORPORATION | 1 | $16 |
| Tempus AI, Inc | 1 | $15 |
Products named: EPKINLY, CARVYKTI, TECVAYLI, TALVEY, LYNOZYFIC, XPOVIO, NINLARO, SARCLISA.
Industry payments across TX — which companies pay providers there.
